18 July 2019 - - US-based Puma biotechnology, Inc. (NASDAQ: PBYI) licensing partner Knight Therapeutics Inc. (Knight) has received marketing authorisation from Health Canada to commercialise Nerlynx (neratinib) in Canada for the extended adjuvant tre...
18 July 2019 - - The US Food and Drug Administration has approved Recarbrio (imipenem, cilastatin, and relebactam) for injection, 1.25 grams, a new combination antibacterial, US-based pharmaceutical company Merck (NYSE: MRK) said.
Recarbrio is ...
18 July 2019 - - US-based biotechnology company Pandion Therapeutics, Inc has appointed Rahul Kakkar, MD, FACC as chief executive officer and as a member of the company's board of directors, the company said.
Kakkar is a biotech entreprene...
18 July 2019 - - The journal OncoImmunology has published results from nonclinical research conducted by US-based biotechnology company Intensity Therapeutics, Inc in partnership with the National Cancer Institute's Vaccine Branch unde...
18 July 2019 - - UK-based biopharmaceutical company PureTech Health plc (LSE: PRTC) has acquired and plans to develop a clinical-stage product candidate for the potential treatment of lymphatic and immunofibrotic diseases, including lymphedema, the c...